Follow the Diaceutics PLC share price and the full insider trade history of the company, a listed equity based in United Kingdom. Shares are listed on the UK market, under the authority of RNS (LSE). Market capitalisation: €126.1m. The latest transaction was disclosed on 7 March 2024 (Purchase). Among the most active insiders: Graham Patterson. All data is openly available.
Analysts rate Diaceutics PLC Strong Buy (bullish), based on 5 analysts. Average price target: £213.00.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Diaceutics PLC 是一家专注于健康数据分析的公司,旨在通过个性化治疗改善患者预后。它主要在英国市场运营,并专注于优化诊断测试。